KMICB - Hydroxycarbamide (shared care guidance)
KMICB Hydroxycarbamide for myeloproliferative disorders sickle cell disease for patients in adults June 2025 V1
KMICB Hydroxycarbamide Shared Care Request Letter
KMICB Hydroxycarbamide Shared Care Agreement Letter
KMICB Hydroxycarbamide Shared Care Refusal Letter
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary